Stockreport

INmune Bio Announces Upcoming Webinar to Present New Clinical Data on CORDStrom™ for RDEB

INmune Bio Inc. - Common stock  (INMB) 
PDF Clinical investigators from the trial to share real-world experience treating RDEB patients with CORDStrom and present new data from the MissionEB clinical study Boca R [Read more]